Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Escribano

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Blood Advances|April 28, 2026
Endothelial Activation and Damage associated with Steroid-Refractory aGVHD is counteracted by RuxolitinibBlanca De Moner, Julia Martinez-Sanchez, Silvia Escribano-Serrat, et al.
Frontiers in Endocrinology|November 28, 2022
Free triiodothyronine levels and age influences the metabolic profile and COVID-19 severity parameters in euthyroid and levothyroxine-treated patientsInés Amich, Eduardo Anguita, Silvia Escribano-Serrat, et al.
Transplantation and Cellular Therapy|November 3, 2025
Antibody Titers of Vaccine-Preventable Pathogens at 1 Year Post CD19 CAR-T Cell TherapySilvia Escribano-Serrat, Nishi Shah, Sigrun Einarsdottir, et al.
Heart & Lung : the Journal of Critical Care|June 18, 2026
Impaired hemostasis in mechanical circulatory support systems: Monitoring with T-TAS® 01, in vitro correction with VWF concentrates, and impact of membrane oxygenatorsSilvia Escribano-Serrat, Ana Belén Moreno-Castaño, Marc Pino, et al.
Journal of Clinical Medicine|February 10, 2024
e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular ResponseSílvia Marcé, Aleix Méndez, Blanca Xicoy, et al.
Transplantation and Cellular Therapy|November 24, 2023
Easix Score Correlates With Endothelial Dysfunction Biomarkers and Predicts Risk of Acute Graft-Versus-Host Disease After Allogeneic TransplantationAlexandra Pedraza, María Queralt Salas, Luis Gerardo Rodríguez-Lobato, et al.
Frontiers in Immunology|December 3, 2025
EASIX, a new tool to predict response and refractoriness in immune-mediated thrombotic thrombocytopenic purpuraSilvia Escribano-Serrat, María Queralt Salas, Cristina Pascual-Izquierdo, et al.
Haematologica|October 30, 2025
Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma after frontline DA-EPOCH-RBrian Hess, Alison Moskowitz, James A Davis, et al.
Bone Marrow Transplantation|August 8, 2024
Safety and efficacy of G-CSF after allogeneic hematopoietic cell transplantation using post-transplant cyclophosphamide: clinical and in vitro examination of endothelial activationSilvia Escribano-Serrat, Alexandra Pedraza, María Suárez-Lledó, et al.
Cytotherapy|November 12, 2023
Endothelial Activation and Stress Index in adults undergoing allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based prophylaxisSilvia Escribano-Serrat, Luis Gerardo Rodríguez-Lobato, Paola Charry, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Blood Advances|April 28, 2026
Endothelial Activation and Damage associated with Steroid-Refractory aGVHD is counteracted by RuxolitinibBlanca De Moner, Julia Martinez-Sanchez, Silvia Escribano-Serrat, et al.
Frontiers in Endocrinology|November 28, 2022
Free triiodothyronine levels and age influences the metabolic profile and COVID-19 severity parameters in euthyroid and levothyroxine-treated patientsInés Amich, Eduardo Anguita, Silvia Escribano-Serrat, et al.
Transplantation and Cellular Therapy|November 3, 2025
Antibody Titers of Vaccine-Preventable Pathogens at 1 Year Post CD19 CAR-T Cell TherapySilvia Escribano-Serrat, Nishi Shah, Sigrun Einarsdottir, et al.
Heart & Lung : the Journal of Critical Care|June 18, 2026
Impaired hemostasis in mechanical circulatory support systems: Monitoring with T-TAS® 01, in vitro correction with VWF concentrates, and impact of membrane oxygenatorsSilvia Escribano-Serrat, Ana Belén Moreno-Castaño, Marc Pino, et al.
Journal of Clinical Medicine|February 10, 2024
e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular ResponseSílvia Marcé, Aleix Méndez, Blanca Xicoy, et al.
Transplantation and Cellular Therapy|November 24, 2023
Easix Score Correlates With Endothelial Dysfunction Biomarkers and Predicts Risk of Acute Graft-Versus-Host Disease After Allogeneic TransplantationAlexandra Pedraza, María Queralt Salas, Luis Gerardo Rodríguez-Lobato, et al.
Frontiers in Immunology|December 3, 2025
EASIX, a new tool to predict response and refractoriness in immune-mediated thrombotic thrombocytopenic purpuraSilvia Escribano-Serrat, María Queralt Salas, Cristina Pascual-Izquierdo, et al.
Haematologica|October 30, 2025
Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma after frontline DA-EPOCH-RBrian Hess, Alison Moskowitz, James A Davis, et al.
Bone Marrow Transplantation|August 8, 2024
Safety and efficacy of G-CSF after allogeneic hematopoietic cell transplantation using post-transplant cyclophosphamide: clinical and in vitro examination of endothelial activationSilvia Escribano-Serrat, Alexandra Pedraza, María Suárez-Lledó, et al.
Cytotherapy|November 12, 2023
Endothelial Activation and Stress Index in adults undergoing allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based prophylaxisSilvia Escribano-Serrat, Luis Gerardo Rodríguez-Lobato, Paola Charry, et al.
Pageof 8